Judith Waltz Comments on Health Care Compliance Predictions for 2022
10 January 2022
Report on Medicare Compliance
Foley & Lardner LLP Partner Judith Waltz was quoted in the article, “Outlook 2022: New Year Brings Big Billing Changes, More Audits, Key Supreme Court Cases,” in the Report on Medicare Compliance, published by the Health Care Compliance Association (HCCA).
In regards to health care organizations preparing to let go of COVID-19 waivers, she says that “we have to start thinking about the post-public health emergency (PHE) even if we don’t know when it will end.” The U.S. Department of Health and Human Services (HHS) may declare the PHE is over “before clinically we can say there is an end to the pandemic.”
Waltz is the co-chair of the firm’s Health Care Practice Group and Health Care Industry Team.
People
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."